Cite
Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review.
MLA
Duan, Fang-Lei, et al. “Clinicopathological Features of Rhabdomyosarcoma with Novel FET::TFCP2 and TIMP3::ALK Fusion: Report of Two Cases and Literature Review.” Histopathology, vol. 82, no. 3, Feb. 2023, pp. 478–84. EBSCOhost, https://doi.org/10.1111/his.14833.
APA
Duan, F.-L., Yang, H., Gong, X., Zuo, Z., Qin, S., Ji, J., Zhou, C., Dai, J., Guo, P., & Liu, Y. (2023). Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review. Histopathology, 82(3), 478–484. https://doi.org/10.1111/his.14833
Chicago
Duan, Fang-Lei, Hong Yang, Xiaojin Gong, Zuo Zuo, Sheng Qin, Juan Ji, Chengmin Zhou, Jie Dai, Peng Guo, and Yang Liu. 2023. “Clinicopathological Features of Rhabdomyosarcoma with Novel FET::TFCP2 and TIMP3::ALK Fusion: Report of Two Cases and Literature Review.” Histopathology 82 (3): 478–84. doi:10.1111/his.14833.